Several studies have shown that INSRR is an insulin receptor-related protein that can enhance the proliferation of several human breast cancer cell lines, possibly because of its synergistic effect with estrogen and insulin-like growth factor (IGF) [29, 30]. Here, IGF1 is linked to breast carcinoma.